|
Demographics
|
|
|
|
|
| Age in months, median (IQR) |
1154 |
29 (11–72) |
48 (21–90) |
0.0001 |
| Female sex, n (%) |
1732 |
78/196 (40) |
638/1536 (42) |
0.64 |
| Electricity at home, n (%) |
734 |
88/101 (87) |
567/633 (90) |
0.46 |
| Complete vaccinations for age, n (%) |
631 |
63/90 (70) |
361/541 (67) |
0.54 |
|
History of acute illness
|
|
|
|
|
| Fever in days, median (IQR) |
881 |
4 (3–7) |
3 (2–6) |
0.0003 |
| Previous fever and/or malaria treatment, n (%) |
617 |
70/95 (74) |
316/522 (61) |
0.015 |
| Previous antibiotics, n (%) |
434 |
28/70 (40) |
74/364 (20) |
0.0007 |
|
Findings on admission
|
|
|
|
|
| Seizures, n (%) |
942 |
89/129 (69) |
596/813 (73) |
0.31 |
| Altered level of consciousness, n (%) |
954 |
94/129 (73) |
609/825 (74) |
0.82 |
| Shock#, n (%) |
743 |
3/103 (3) |
20/640 (3) |
>0.99 |
| Dyspnea, n (%) |
930 |
78/133 (59) |
375/797 (47) |
0.013 |
| Dehydration, n (%) |
886 |
38/125 (30) |
147/761 (19) |
0.005 |
| Malnutrition, n (%) |
908 |
42/128 (33) |
164/780 (21) |
0.003 |
|
Laboratory tests
|
|
|
|
|
| Sickle cell disease, n (%) |
742 |
19/105 (18) |
24/637 (4) |
<0.0001 |
| Malaria test positive, n (%) |
432 |
14/57 (25) |
224/375 (60) |
<0.0001 |
| HIV positive, n (%) |
741 |
3/105 (3) |
14/636 (2) |
0.72 |